The Financial Conduct Authority just ordered banks to improve access to basic accounts. Here's what it means for financial inclusion and consumer protection in the United Kingdom.
1️⃣ Financial Conduct Authority — Banks told to improve access to basic accounts
The regulator published a press release demanding that financial institutions enhance the accessibility of basic banking services for underserved populations across the country.
This development impacts UK-based retail banks and payment service providers who are responsible for maintaining inclusive consumer protection standards in every branch.
Lenders must now review internal account opening procedures and digital interfaces to ensure they meet the needs of consumers facing barriers to standard services.
2️⃣ European Systemic Risk Board — Vulnerabilities from frontier AI models
The ESRB issued a formal warning regarding systemic risks and operational vulnerabilities created by the rapid adoption of large-scale frontier artificial intelligence models.
The alert targets financial institutions integrating AI into critical operations and complex risk management frameworks within the European Union territory.
Firms are expected to align technological deployments with the Digital Operational Resilience Act while strengthening cybersecurity and ICT risk mitigation strategies immediately.
3️⃣ Health and Safety Executive — Emma Bridgewater fined after child injury
A manufacturing firm was ordered to pay £266,666 following a prosecution for workplace safety failures that caused a shard of glass to injure a member of the public.
This action hits manufacturing businesses and retail operations that must ensure strict adherence to health and safety protocols within their industrial facilities.
Organizations should conduct thorough risk assessments and maintain heavy equipment to prevent catastrophic injuries and subsequent heavy financial penalties or legal actions.
4️⃣ Medicines and Healthcare products Regulatory Agency — Scientific opinion on TK2d treatments
The agency released a scientific opinion concerning the use of Doxecitine and Doxribtimine for treating thymidine kinase 2 deficiency in clinical settings.
This update is critical for pharmaceutical companies and medical device manufacturers involved in developing specialized treatments for rare genetic conditions and diseases.
Stakeholders should monitor the transition to formal drug approval to plan for the commercialization and distribution of these healthcare products internationally.
5️⃣ Autoriteit Consument & Markt — Investigation into cartel for public sector suppliers
The Dutch competition authority announced an investigation into potential price-fixing agreements among companies providing goods and services to various public sector institutions.
The probe impacts suppliers participating in public procurement processes and government tenders within the Netherlands and the broader European Union markets.
Impacted organizations should conduct internal audits of bidding practices and cooperate with investigators to mitigate potential fines and reputational damage.
Full analysis in the attached RegNext Daily Europe Radar carousel.
— Elena Navarro · Managing Editor, RegNext
Daily Europe Radar · Tuesday 07 Jul 2026
#EURegulation #UKRegulation #FinancialRegulation #ComplianceIntelligence
